In this work led by Davide Recchia, we use engineered Chromatin Readers (eCRs) to evaluate target specificity of Bromodomain inhibitors and PROTACs.
In this work led by Davide Recchia, we use engineered Chromatin Readers (eCRs) to evaluate target specificity of Bromodomain inhibitors and PROTACs.